drugset / Trial / NCT02980926

Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty

NCT02980926

Phase 4 Completed 32 enrolled Henry Ford Health System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if a shorter-acting spinal anesthetic called mepivacaine has advantages over a longer-acting medication called bupivacaine.

Timeline

Start
2016-12
Primary completion
2017-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 12 mg
Subject Mepivacaine Other / unclassified 3 ml Intrathecal

Indications